CRSP crisprtx.com: Net Margin

crisprtx.com (CRSP) - corporate logo

The first gene therapy approvals establish a foundation for profitability, although cash flow remains limited by partnerships. The GURU.Markets interface displays this chart, where the commercial profit margin of CRISPR Therapeutics AG (CRSP) reaches -1812.10, reflecting the latest data. Business efficiency is supported by complex cryogenic logistics for biomaterials. Simultaneously, CRISPR Therapeutics AG (CRSP) is implementing green standards and clean energy across its laboratories.

crisprtx.com (CRSP) - Net Margin from 07/04/2022 to 11/20/2026

CRISPR Therapeutics Corp - analytical breakdowns and key metrics (CRSP)

- share price and expert price forecast:
- company stock capitalization data:
Analysis of all company metrics:CRISPR Therapeutics Inc - CRSP
Finished products of CRISPR Therapeutics Inc

For the conservative investor, net margin dynamics serve as an efficiency filter, measuring the portion of net profit in every dollar of revenue after deducting all operating and tax expenses. In the case of CRISPR Therapeutics AG (CRSP), this indicator reflects the balance between the costs of ethical ESG optimization of biolabs and the ability of high-tech gene therapy to generate real free cash flow over the long term.

Main competitors

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|Company Sales Margin GeneDx|Net Margin Ultragenyx RARE|Company Sales Margin Beam Therapeutics (BEAM)|SRPT: Return on Sales by Net Profit|Net Margin Twist Bioscience|TXG (10x Genomics) - Return on Sales by Net Profit|Intellia Therapeutics, Inc. (NTLA) - Net Sales Margin|Net Margin Stoke Therapeutics Inc|BLFS: Net Profit Rate|Return on Sales by Net Profit WVE (Wave Life Sciences Corp)|Company Sales Margin Maze Therapeutics Corp|Sionna Therapeutics Inc - Return on Sales by Net Profit|PRME (primemedicine.com) - Net Profit Margin|TSHA - Net Margin|QURE (uniQure) - Net Return on Sales|MeiraGTx Corp (MGTX) - Net Margin|Regenxbio - Net Profit Rate|Net Margin solidbio.com|Net Margin ocugen.com OCGN|Net Sales Margin PACB|Benitec - Net Return on Sales|Net Margin Design Therapeutics DSGN|Net Sales Margin Rocket Pharmaceuticals RCKT|Net Profit Margin 4D Molecular Corp|LXEO: Net Margin|KRRO (Korro Bio, Inc) - Return on Sales by Net Profit|Editas Medicine (EDIT) - Net Sales Margin|Net Margin Silence Therapeutics Inc.|Net Return on Sales PRQR (proqr.com)|Net Margin Codexis Bio (CDXS)|Net Sales Margin sangamo.com (SGMO)|Net Margin nautilus.bio NAUT|Company Sales Margin Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX